Advertisement

European Journal of Clinical Pharmacology

, Volume 9, Issue 1, pp 27–37 | Cite as

Comparative study of the cardiac and peripheral vascular effects of strophantin K and lanatoside C in coronary heart disease

  • L. Matos
  • M. Békés
  • G. Polák
  • J. Rausch
  • E. Török
Originals

Summary

The effects of intravenous strophanthin K (0.125 and 0.25 mg) and lanatoside C (0.4, 0.8 and 1.6 mg) on systolic time intervals (STI) and impedance plethysmographic (IP) values were studied in ten patients with compensated coronary heart disease. The heart rate decreased significantly during a two-hour study in the lying position after both glycosides and placebo; the systemic blood pressure remained unchanged. Electromechanical systole (QS2), left ventricular ejection time (LVET) and preejection period (PEP), corrected for heart rate (QS2I, LVETI, PEPI), showed no change after placebo. The glycosides caused no change in LVETI. QS2I was significantly shortened only after lanatoside C 1.6 mg. PEPI and ICT were significantly shortened by both doses of strophanthin K and lanatoside C; the effects were dose-related. Taking into consideration the effects of cardiac glycosides on STI, use of the index ICT/QS1, the quotient of isovolumic contraction time and electromechanical delay, is proposed, because it showed quite sensitively the increase in myocardial contractility after digitalis. The effect of strophanthin K could be detected 10 minutes, and that of lanatoside C 30–40 minutes, after injection. The amplitude of the IP curve and the relative pulse volume showed positive and negative changes without any trend after administration of placebo or glycoside. The data suggests that the usual therapeutic doses of these cardiac glycosides do not cause significant changes in the peripheral circulation in patients with compensated coronary heart disease, but their action on STI is quite marked, showing a positive inotropic effect.

Key words

Lanatoside C strophanthin K positive inotropic effect impedance plethysmography systolic time intervals coronary heart disease 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Weissler, A.M., Gamel, W.G., Grode, H.E., Cohen, S., Schoenfeld, C.D.: The effect of digitalis on ventricular ejection in normal human subjects. Circulation29 721–729 (1964)Google Scholar
  2. 2.
    Weissler, A.M., Kamen, A.R., Bornstein, R.S., Schoenfeld, C.D., Cohen, S.: The effect of deslanoside on the duration of the phases of ventricular systole in man. Amer. J. Cardiol.15 153–161 (1965)Google Scholar
  3. 3.
    Weissler, A.M., Snyder, J.R., Schoenfeld, C.D., Cohen, S.: Assay of digitalis glycosides in man. Amer. J. Cardiol.17 768–780 (1966)Google Scholar
  4. 4.
    Kaindl, F., Polzer, K., Schufried, F.: Rheographie. Eine Methode zur Beurteilung peripherer Gefässe. Darmstadt: Dietrich Steinkopff Verlag 1959Google Scholar
  5. 5.
    Eninya, G.I., Smeltere, E.S.: Comparative characteristics of the action produced by Dibazol on the cerebral circulation. (In Russian). Soviet. Med.36 136–137 (1973)Google Scholar
  6. 6.
    Békés, M., Gulyas, A., Kusztos, D.: Clinical evaluation of longacting nitrite compounds on the basis of their pharmacodynamic action. V. Conf. Hung. Ther. Invest. Pharmacol., Budapest, 1969, pp 231–233Google Scholar
  7. 7.
    Weissler, A.M., Harris, W.S., Schoenfeld, C.D.: Bedside technics for the evaluation of ventricular function in man. Amer. J. Cardiol.23, 577–583 (1969)Google Scholar
  8. 8.
    Weissler, A.M.: Resting and exercise systolic intervals. Circulation46, 633 (1972)Google Scholar
  9. 9.
    Spidick, D.H., Kumar, S., Flessas, A.P., Sriratanaban, A.D., Sosler, G., Klints, R.V., Muench, H.: Relationship of paper speed to precision of pulse wave measurements: A multiple observer study of left ventricular ejection time. Aerospace Med.40, 707–709 (1969)Google Scholar
  10. 10.
    Polzer, K., Schufried, F.: Die physikalischen Untersuchungsmethoden peripherer Gefässe unter besonderer Berücksichtigung der Rheographie. Ärztl. Forsch.10, 366–369 (1960)Google Scholar
  11. 11.
    Schufried, F.: Rheographie. Ärztl. Forsch.15, 455–462 (1961)Google Scholar
  12. 12.
    Fraenkel, A.: Strophanthintherapie. Berlin: Julius Springer Verlag: 1933Google Scholar
  13. 13.
    Laurence, D.R.: Clinical pharmacology. 3rd ed., London: J.A. Churchill Ltd. 1966Google Scholar
  14. 14.
    Selden, R., Smith, R.W.: Ouabain pharmacokinetics in dog and man. Determination by radioimmunoassay. Circulation45, 1176–1182 (1972)Google Scholar
  15. 15.
    Ross, J. jr., Braunwald, E., Waldhausen, J.A.: Studies on digitalis. II. Extracardiac effects on venous return and on the capacity of the peripheral vascular bed. J. clin. Invest.39, 937–942 (1960)Google Scholar
  16. 16.
    Ross, J. jr., Waldhausen, J.A., Braunwald, E.: Studies on digitalis. I. Direct effects on peripheral vascular resistance. J. clin. Invest.39, 930–936 (1960)Google Scholar
  17. 17.
    Braunwald, E., Bloodwell, R.D., Goldberg, L.I., Morrow, A.G.: Studies on digitalis. IV. Observations in man on the effects of digitalis preparations on the contractility of the non-failing heart and on total vascular resistance. J. clin. Invest.40, 52–59 (1961)Google Scholar
  18. 18.
    Weissler, A.M., Schoenfeld, C.D.: Effect of digitalis on systolic time intervals in heart failure. Amer. J. med. Sci.259, 4–20 (1970)Google Scholar
  19. 19.
    Wilson, W.S., Tolbert, J.H., DiGiulio, W.: Plasma digitoxin levels and serial left ventricular ejection times after a digitalizing dose of digitoxin. Amer. J. Cardiol.26, 162–164 (1970)Google Scholar
  20. 20.
    Shaver, J.A., Kroetz, F.W., Leonard, J.J., Paley, H.W.: The effect of steady-state increases in systemic arterial pressure on the duration of left ventricular ejection time. J. clin. Invest.47, 217–230 (1968)Google Scholar
  21. 21.
    Hodges, M., Friesinger, G.C., Riggins, R.C., Dagenais, G.R.: Effects of intravenously administered digoxin on mild left ventricular failure in acute myocardial infarction in man. Amer. J. Cardiol.29, 749–756 (1972)Google Scholar
  22. 22.
    Levy, A.M., Leaman, D.M., Hanson, J.S.: Effects of digoxin on systolic time intervals of neonates and infants. Circulation46, 816–823 (1972)Google Scholar
  23. 23.
    Wallace, A.G., Mitchell, J.H., Skinner, N.S., Sarnoff, S.J.: Duration of the phases of left ventricular systole. Circulat. Res.12, 611–619 (1963)Google Scholar
  24. 24.
    Gábor, Gy.: A systole dynamikája a sziv ép és kóros állapotában. Doktori disszertáció, Budapest, 1965Google Scholar
  25. 25.
    Austin, T.W., Ahuja, S.P., Boughner, D.R.: Atraumatic study of left ventricular events following acute myocardial infarction. Amer. J. Cardiol.29, 745–748 (1972)Google Scholar
  26. 26.
    Sambhi, M.P.: The isometric period of contraction as a determinant of cardiac performance and digitalis action. Amer. J. Cardiol.6, 1042–1048 (1960)Google Scholar
  27. 27.
    Apor, P.: Adatok a nyugalmi, “normál” szivciklusértékek kérdéséhez. Magy. belorv. Arch.25, 134–140 (1972)Google Scholar
  28. 28.
    Aronow, W.S., Bowyer, A.F., Kaplan, M.A.: External isovolumic contraction times and left ventricular ejection time/external isovolumic contraction time ratios at rest and after exercise in coronary heart disease. Circulation43, 59–65 (1971)Google Scholar
  29. 29.
    Bodrogi, Gy., Kálmán, P., Kusztos, D.: Über die Rolle der Rheokardiographie bei der Bestimmung der einzelnen Herzphasen. Acta med. Acad. Sci. Hung.18, 189 (1962)Google Scholar
  30. 30.
    Jaeger, H., Gutmann, J., Ruhenstroth-Bauer, G.: Methodische Untersuchungen zur klinischen Anwendung der Direktrheographie. Klin. Wschr.50, 967 (1972)Google Scholar
  31. 31.
    Mullick, S.C., Wheeler, H.B., Songster, G.F.: Diagnosis of deep venous thrombosis by measurement of electrical impedance. Amer. J. Surg.119, 417 (1970)Google Scholar
  32. 32.
    Van de Water, J.M., Mount, B.E., Barela, J.R., Schuster, R., Laecock, F.S.: Monitoring the chest with impedance. Chest64, 597 (1973)Google Scholar
  33. 33.
    Brokaert, A., Godfraind, T.: The actions of ouabain on isolated arteries. Arch. int. Pharmacodyn.203, 393–395 (1973)Google Scholar
  34. 34.
    Bloor, C.M., Walker, D.E., Pensinger, R.R.: Ouabain induced primary coronary vasocontriction. Proc. Soc. exp. Biol. (N.Y.)140, 1409–1413 (1972)Google Scholar
  35. 35.
    Stark, J.J., Sanders, C.A., Powell, Wm.J., jr.: Neurally mediated and direct effects of acetylstrophanthidin on canine skeletal muscle vascular resistance. Circul. Res.30, 274–282 (1972)Google Scholar
  36. 36.
    Archer, L.T., Hinshaw, L.B.: Dose-response effects of cardiac glycosides on pooling and systemic and pulmonary haemodynamics. Canad. J. Physiol. Pharmacol.48, 533–541 (1970)Google Scholar
  37. 37.
    Solti, F., Iskum, M.: Effect of strophanthin on venous pressure and on venous tone. Acta med. Acad. Sci. hung.14, 397–403 (1959)Google Scholar
  38. 38.
    Mason, D.T., Braunwald, E.: Studies on digitalis. X. Effects of ouabain on forearm vascular resistance and venous tone in normal subjects and in patients in heart failure. J. clin. Invest.43, 532–543 (1964)Google Scholar
  39. 39.
    Glover, W.E., Hanna, M.J.D., Speden, R.N.: Actions of cardiac glycosides on the vessels of the forearm and hand. Cardiovasc. Res.1, 341–348 (1967)Google Scholar
  40. 40.
    Kumar, R., Hood, W.B., jr., Gilmour, D.P., Abelmann, W.H.: Effects of acetylstrophanthidin on cardiovascular function in intact, conscious dogs. J. Pharmacol. exp. Ther.180, 24–30 (1972)Google Scholar
  41. 41.
    Dresdale, D.T., Yuceoglu, Y.Z., Michtom, Schultz, M., Lunger, M.: Effects of lanatoside C on cardiovascular haemodynamics. Acute digitalizing doses in subjects with normal hearts and with heart disease without failure. Amer. J. Cardiol.4, 88–99 (1959)Google Scholar
  42. 42.
    Mason, D.T., Braunwald, E.: Studies on digitalis. IX. Effects of ouabain on the nonfailing human heart. J. clin. Invest.42, 1105–1111 (1963)Google Scholar
  43. 43.
    Gorsch, K., Klein, W.W., Leb, G., Pavek, P., Passath, A.: Hämodynamische Vergleichsuntersuchungen verschiedener Herzglykoside. Z. Kreisl.-Forsch.61, 577–587 (1972)Google Scholar
  44. 44.
    Ogilvie, R.I., Ruedy, J.: An educational program in digitalis therapy. J. Amer. med. Ass.222, 50–55 (1972)Google Scholar
  45. 45.
    Rubin, I.L., Arbeit, S.R., Gross, H.: Diuretics versus digitalis in the treatment of congestive heart failure. J. clin. Pharmacol.12, 121–122 (1972)Google Scholar

Copyright information

© Springer-Verlag 1975

Authors and Affiliations

  • L. Matos
    • 1
  • M. Békés
    • 1
  • G. Polák
    • 1
  • J. Rausch
    • 1
  • E. Török
    • 1
  1. 1.Department of Clinical PharmacologyHungarian Institute of CardiologyBudapestHungary

Personalised recommendations